Page 8 - Peter Marks News Today

The groundbreaking rock musical opened April 29, 1968, at Broadway's Biltmore Theatre.

Smithsonian Associates will present a celebration of HAIR: The American Tribal Love-Rock Musical in collaboration with the Smithsonian’s National Museum of American History. Learn more about the event!

US Panel Recommends Pfizer Covid Vaccine For Younger Children : Rashtra News A Pfizer analysis showed the vaccine was 90.7% effective at preventing symptomatic CovidWashington: A medical panel of US government advisors endorsed the Pfizer Covid-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.The independent experts concluded

Sunday, April 7, 2024 -- An earthquake. An eclipse. A bridge collapse. A freak blizzard. A biblical flood. Apocalyptic vibes are stirred by Donald Trumps violent rhetoric and talk of blood baths. ... An unspoken Trump threat is there will be a blood bath in Washington, like Jan. 6, if he doesnt win.

Trump’s raw power grab after his 2020 loss may have failed, but he’s inflaming his base with language straight out of Macbeth’s trip to hell

The present case is the first involving a direct transmission from bovines to humans and is also the first time cows have shown susceptibility to this virus, surprising influenza virologists.

Federal health agencies are preparing for possible new cases of human infections from the avian flu virus spreading in dairy and egg farms in the U.S. FDA, CDC, and other officials briefed congressional leaders and committees on the outlook during a call Tuesday.

Local News, Sports, Events, Obits and more from Knox County.

FDA clears Moderna's and Pfizer's Covid vaccine booster shots for all U.S. adults : Rashtra News Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with Pfizer COVID-19 vaccine before giving it to people on the first day that people ages 16 and up can receive the vaccine at Kedren Health on Thursday,

The FDA has made the final decision to withdraw the approval of Pepaxto (melphalan flufenamide) for multiple myeloma.